Monoamine Oxidase Inhibitors (MAOIs)

Eastern / Traditional Medicine Perspective

Traditional systems such as Traditional Chinese Medicine (TCM) and Ayurveda do not historically describe illness in terms of monoamine oxidase enzymes or neurotransmitter reuptake. Instead, conditions for which MAOIs may be prescribed—such as low mood, fatigue, slowed vitality, anxiety, sleep disruption, or neurologic symptoms—are interpreted through broader functional patterns. In TCM, these presentations may be discussed in relation to Shen disturbance, Liver qi stagnation, Heart and Spleen deficiency, or Kidney essence depletion, depending on the symptom picture. In Ayurveda, related concerns may be framed through imbalances involving manas, ojas, and the doshas, especially Vata and Kapha patterns in mental and neurologic health.

Within these traditions, emphasis is often placed on individualized assessment, digestion, sleep, stress, emotional regulation, movement of energy, and constitutional balance. Herbal medicine, acupuncture, bodywork, breathing practices, meditation, and dietary patterning may all be considered as part of a broader supportive framework. However, from an integrative safety perspective, MAOIs warrant exceptional caution because many traditional remedies and fermented preparations may have pharmacologic overlap or interaction risk. Herbs or supplements with serotonergic, stimulant, sympathomimetic, or tyramine-related effects are of particular concern in people taking MAOIs.

Naturopathic and integrative practitioners commonly view MAOIs as medications that require high-level coordination when complementary approaches are being considered. Even natural products often perceived as gentle—such as certain mood-supportive botanicals, amino acid supplements, or concentrated extracts—may be inappropriate in this context because of potential interaction risks. As a result, traditional and integrative perspectives generally place strong emphasis on collaboration with the prescribing medical team, careful review of all supplements and formulas, and avoidance of assumptions that natural products are automatically compatible with psychiatric medications.

In summary, eastern and traditional systems may offer broader conceptual frameworks for the person’s overall pattern of imbalance, but they do not replace the pharmacologic realities of MAOI therapy. Integrative care discussions around MAOIs are therefore shaped less by traditional use alone and more by the need for safe, individualized, and well-coordinated interdisciplinary care.